密爾克衞(603713.SH):2021年度淨利潤預增44%-51%
格隆匯1月12日丨密爾克衞(603713.SH)公佈,預計2021年年度實現歸屬於上市公司股東的淨利潤與上年同期相比,將增加12693.95萬元到14713.44萬元,同比增長44%到51%;歸屬於上市公司股東的扣除非經常性損益的淨利潤與上年同期相比,將增加12288.49萬元到14307.98萬元,同比增長45.05%到52.46%。
報吿期內,公司積極保增長擴收入、優化經營結構、加強核心能力建設及內部管理體系、提高效率及服務質量、增加企業競爭力。
本期歸屬於上市公司非經常性損益金額税後約為1980萬元,較上期增加約405.46萬元,主要原因為報吿期內政府補貼增加。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.